CompletedPhase 3NCT00047125
Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
Studying Cancer of unknown primary site
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Principal Investigator
- Vincent G. Gregoire, MD, PhDCliniques universitaires Saint-Luc- Université Catholique de Louvain
- Intervention
- radiation therapy(radiation)
- Enrollment
- 600 enrolled
- Eligibility
- 18-120 years · FEMALE
- Timeline
- 2002
Study locations (30)
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
- Comprehensive Cancer Institute, Huntsville, Alabama, United States
- MBCCOP - Gulf Coast, Mobile, Alabama, United States
- Montgomery Cancer Center, Montgomery, Alabama, United States
- DCH Cancer Treatment Center, Tuscaloosa, Alabama, United States
- Foundation for Cancer Research and Education, Phoenix, Arizona, United States
- Providence Saint Joseph Medical Center - Burbank, Burbank, California, United States
- Mount Diablo Medical Center, Concord, California, United States
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
- California Cancer Center, Fresno, California, United States
- Saint Agnes Cancer Center, Fresno, California, United States
- Sutter Health Western Division Cancer Research Group, Greenbrae, California, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center, Loma Linda, California, United States
- Veterans Affairs Medical Center - Long Beach, Long Beach, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Radiation Therapy Oncology Group · NCIC Clinical Trials Group · Danish Head and Neck Cancer Group
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00047125 on ClinicalTrials.govOther trials for Cancer of unknown primary site
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07524114Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)University Health Network, Toronto
- RECRUITINGNANCT07283939Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment DelaysAlliance for Clinical Trials in Oncology
- RECRUITINGPHASE2NCT06995508Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO TrialRoswell Park Cancer Institute
- RECRUITINGPHASE1NCT06868433TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell CancerEmory University
- RECRUITINGPHASE3NCT06589804Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous TreatmentNational Cancer Institute (NCI)
- RECRUITINGNANCT06662058Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or RadiationEmory University
- RECRUITINGPHASE2NCT06636734Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP TrialEmory University
- RECRUITINGNANCT06644716[18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary OriginErasmus Medical Center